Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Return on Invested Capital (2024 - 2025)

Connect Biopharma Holdings' Return on Invested Capital history spans 2 years, with the latest figure at 0.83% for Q3 2025.

  • For Q3 2025, Return on Invested Capital changed N/A year-over-year to 0.83%; the TTM value through Sep 2025 reached 0.83%, changed N/A, while the annual FY2024 figure was 0.24%, N/A changed from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.83% at Connect Biopharma Holdings, down from 0.63% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.24% in Q4 2024 and bottomed at 0.83% in Q3 2025.